While tariffs are front and center for markets, a handful of other issues is weighing on investor confidence as the second ...

U.S. stock-market volatility was rising Monday as reciprocal tariffs loom this week, with the S&P 500 struggling in 2025 amid ...

Rising inflation continued to batter the economy and consumer spending as our trading session ended March 28, 2025.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

These shares are avoiding the market weakness on Thursday. But why? The post Why Core Lithium, Healius, Neuren, and Reject ...

Domain (DHG), Ecograf (EGR), Firefly Metals (FFM), Gorilla Gold Mines (GG8), Genesis Minerals (GMD), JB HI-FI (JBH), Larvotto Resources (LRV), Spartan Resources (SPR), Vulcan Energy (VUL). Interesting ...

The Australian share market has ended its five-day winning streak after the looming threat of tariffs on US car imports ...

While the US biotechnology sector has swooned on concerns about new US healthcare policies, the ASX 'Magnificent Seven' has soared.

Helene Meisler analyzes a bearish and oversold stock market, and how sentiment shifts could trigger a bullish rally.

Neuren Pharmaceuticals (ASX:NEU ... with a long-term vision of developing a market-dominant therapy for multiple neurodevelopmental disorders.

When you incorporate the effect of inflation, one dollar (in 1870 US dollars) invested in a hypothetical US stock market index in 1871 would have grown to $30,711 by the end of February 2025.

Learn More Neuren Pharmaceuticals Ltd (ASX: NEU) shares were out of form on Tuesday after getting caught up in the market selloff. The ASX 200 stock ended the day 6% lower at $11.40. This leaves ...